NCT lookup
Pull any trial record directly from ClinicalTrials.gov.
Sponsor: Associacao para Investigacao e Desenvolvimento da Faculdade de Medicina - CETERA
Conditions: Type2 Diabetes Mellitus, Coronary Heart Disease
Interventions: Exposure to Anti-thrombotic treatment agents and glucose lowering therapy
Countries: Portugal
Diabetes mellitus (DM) is one of the main risk factors for ischemic events in patients with coronary artery disease (CAD) and diabetes is a factor in several post-PCI (Percutaneous Coronary Intervention) risk scores. However, until recently, there were almost no studies performed specifically in the diabetic population of patients undergoing PCI. This study aims to describe the anti-thrombotic regimens, clinical outcomes and current diabetes medical treatment in an unselected consecutive population of patients with DM undergoing PCI.
Sex: ALL
Age: 18 Years to —
Healthy volunteers: No
Study type: OBSERVATIONAL
Inclusion Criteria: * PCI with stent implantation, performed in at least one major coronary artery in the context of stable coronary artery disease or acute coronary syndrome * Type 2 Diabetes mellitus (previously diagnosed or diagnosed at the index admission) * Informed consent signed * Patient not simultaneously participating in any interventional study Exclusion Criteria: * Patients with Type 1 Diabetes mellitus * Patients whose survival is expected to be lower than 1 year at hospital discharge * Patients not whiling to participate
- Braga, Braga District, Portugal
- Coimbra, Coimbra District, Portugal
- Faro, Faro District, Portugal
- Amadora, Lisbon District, Portugal
- Carnaxide, Lisbon District, Portugal
- Lisbon, Lisbon District, Portugal
- Lisbon, Lisbon District, Portugal
- Porto, Porto District, Portugal
- Vila Nova de Gaia, Porto District, Portugal
- Almada, Setúbal District, Portugal
- Setúbal, Setúbal District, Portugal
- Evora, Évora District, Portugal